1. Home
  2. IDYA

IDYA

IDEAYA Biosciences Inc.

Logo IDEAYA Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

Founded: 2015 Country:
N/A
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 2.8B IPO Year: 2019
Target Price: $45.70 AVG Volume (30 days): 708.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.96 EPS Growth: N/A
52 Week Low/High: $13.55 - $47.74 Next Earning Date: 01-01-0001
Revenue: $23,385,000 Revenue Growth: -54.08%
Revenue Growth (this year): -16.66% Revenue Growth (next year): 462.13%

Share on Social Networks:

Stock Insider Trading Activity of IDEAYA Biosciences Inc. (IDYA)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Hata Yujiro S IDYA President and CEO Feb 1 '24 Sell $45.01 4 $180.04 677,887 SEC Form 4
Hata Yujiro S IDYA President and CEO Feb 1 '24 Sell $45.00 624 $28,080.00 677,891 SEC Form 4
Ruiz Briseno Andres IDYA See Remarks Jan 12 '24 Sell $38.01 2,000 $76,025.60 28,531 SEC Form 4
Hata Yujiro S IDYA President and CEO Dec 15 '23 Sell $35.03 75,000 $2,627,617.50 677,887 SEC Form 4
Ruiz Briseno Andres IDYA See Remarks Dec 14 '23 Sell $34.01 328 $11,153.64 30,531 SEC Form 4
Ruiz Briseno Andres IDYA See Remarks Dec 14 '23 Sell $34.00 1,672 $56,848.00 30,859 SEC Form 4